Therefore, other plasma components, including Interleukin‐8 (IL‐8) and nucleosomes, are currently being explored as potentially more selective biomarkers associated with infection‐related complications in AML patients undergoing chemotherapy [12]. Here, CXCL8 is linked to infection.